Rush Street Interactive Inc (RSI) Stock Price Today
Aura AI Summary
Key Stats
- $2.14BMarket Cap
- 1,458,081Volume
- Consumer CyclicalSector
- $34.5252W High
- $15.8952W Low
- 14 DaysTypical Hold Time
- $1.81BEnterprise Value
- -Div Yield
- -Trading Activity
Track Rush Street Interactive Inc (RSI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Rush Street Interactive Inc has traded between a low of $15.89 and a high of $34.52, highlighting its annual price range. Buy and sell Rush Street Interactive Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Most Recent News
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026
JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.
Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Clinical trial supplies market to nearly double from $5.7B in 2025 to $10.7B by 2033, driven by biologics and decentralized trials
The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personali...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.